PaxMedica, Inc. Common Stock Profile Avatar - Palmy Investing

PaxMedica, Inc. Common Stock

PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intra…

Biotechnology
US, Tarrytown [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

PaxMedica, Inc. Common Stock has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
0.0 IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
YoY Trends
  • No trends presentable at the moment.

Spending By Type

Awards
Obligations
Contracts IDV Contracts Grants Loans Direct Other

PaxMedica, Inc. Common Stock can't present spending by time.

End of PXMD's Analysis
CIK: 1811623 CUSIP: 70424C104 ISIN: US70424C2035 LEI: - UEI: -
Secondary Listings
PXMD has no secondary listings inside our databases.